Henan Lingrui Pharmaceutical Co Ltd
SSE:600285
Wall Street
Price Targets
Price Targets Summary
Henan Lingrui Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for
Henan Lingrui Pharmaceutical Co Ltd
is 29.12 CNY
with a low forecast of 27.37 CNY and a high forecast of 31.5 CNY.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Henan Lingrui Pharmaceutical Co Ltd's stock price target?
Price Target
29.12
CNY
According to Wall Street analysts, the average 1-year price target for
Henan Lingrui Pharmaceutical Co Ltd
is 29.12 CNY
with a low forecast of 27.37 CNY and a high forecast of 31.5 CNY.
What is Henan Lingrui Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
13%
For the last 13 years the
compound annual growth rate for
Henan Lingrui Pharmaceutical Co Ltd's revenue is
17%.
The projected
CAGR
for the next 3 years is
13%.
What is Henan Lingrui Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
12%
For the last 13 years the
compound annual growth rate for
Henan Lingrui Pharmaceutical Co Ltd's operating income is
28%.
The projected
CAGR
for the next 3 years is
12%.
What is Henan Lingrui Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
12%
For the last 13 years the
compound annual growth rate for
Henan Lingrui Pharmaceutical Co Ltd's net income is
28%.
The projected
CAGR
for the next 3 years is
12%.